Baidu
map

肿瘤治疗相关血小板减少症的临床管理专家共识

2021-12-25 中华医学会肿瘤学分会肿瘤支持康复治疗学组 肿瘤

血小板减少症是肿瘤治疗的常见血液学不良反应之一,可增加出血风险、延长住院时间、增加医疗费用,严重时可导致死亡。

中文标题:

肿瘤治疗相关血小板减少症的临床管理专家共识

发布日期:

2021-12-25

简要介绍:

血小板减少症是肿瘤治疗的常见血液学不良反应之一,可增加出血风险、延长住院时间、增加医疗费用,严重时可导致死亡。目前对肿瘤治疗导致血小板减少症的管理尚缺乏高质量的循证证据,多基于小样本临床研究和临床经验,并且大多着眼于化疗所致血小板减少症(chemotherapy-induced thrombocytopenia,CIT)。目前,靶向药物和免疫检查点抑制剂等抗肿瘤药物已广泛进入临床实践,研究报道这些非细胞毒药物亦会引发血小板减少的血液学毒性,并且其导致血小板减少症的机制与CIT不同,因此同样需要有系统而全面的指南与共识对其临床管理进行指导。 

下载附件:

(因为版权问题,不支持下载)

评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2161720, encodeId=1c5f2161e2069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Oct 09 14:15:13 CST 2023, time=2023-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248014, encodeId=634c124801409, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Sep 09 01:12:51 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199889, encodeId=6ae111998896e, content=指南好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed22506458, createdName=124adb5am09暂无昵称, createdTime=Sun Mar 06 12:48:41 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194628, encodeId=846811946280a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1466167480, createdName=ms3000000089219083, createdTime=Thu Feb 17 23:21:43 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191893, encodeId=0f711191893e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d995020738, createdName=3254357, createdTime=Thu Feb 10 17:18:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2023-10-09 妙医生 来自浙江省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2161720, encodeId=1c5f2161e2069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Oct 09 14:15:13 CST 2023, time=2023-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248014, encodeId=634c124801409, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Sep 09 01:12:51 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199889, encodeId=6ae111998896e, content=指南好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed22506458, createdName=124adb5am09暂无昵称, createdTime=Sun Mar 06 12:48:41 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194628, encodeId=846811946280a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1466167480, createdName=ms3000000089219083, createdTime=Thu Feb 17 23:21:43 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191893, encodeId=0f711191893e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d995020738, createdName=3254357, createdTime=Thu Feb 10 17:18:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-09-09 1243a20em71(暂无昵称)

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2161720, encodeId=1c5f2161e2069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Oct 09 14:15:13 CST 2023, time=2023-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248014, encodeId=634c124801409, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Sep 09 01:12:51 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199889, encodeId=6ae111998896e, content=指南好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed22506458, createdName=124adb5am09暂无昵称, createdTime=Sun Mar 06 12:48:41 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194628, encodeId=846811946280a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1466167480, createdName=ms3000000089219083, createdTime=Thu Feb 17 23:21:43 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191893, encodeId=0f711191893e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d995020738, createdName=3254357, createdTime=Thu Feb 10 17:18:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-03-06 124adb5am09暂无昵称

    指南好棒

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2161720, encodeId=1c5f2161e2069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Oct 09 14:15:13 CST 2023, time=2023-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248014, encodeId=634c124801409, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Sep 09 01:12:51 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199889, encodeId=6ae111998896e, content=指南好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed22506458, createdName=124adb5am09暂无昵称, createdTime=Sun Mar 06 12:48:41 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194628, encodeId=846811946280a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1466167480, createdName=ms3000000089219083, createdTime=Thu Feb 17 23:21:43 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191893, encodeId=0f711191893e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d995020738, createdName=3254357, createdTime=Thu Feb 10 17:18:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-17 ms3000000089219083

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2161720, encodeId=1c5f2161e2069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Oct 09 14:15:13 CST 2023, time=2023-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248014, encodeId=634c124801409, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Sep 09 01:12:51 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199889, encodeId=6ae111998896e, content=指南好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed22506458, createdName=124adb5am09暂无昵称, createdTime=Sun Mar 06 12:48:41 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194628, encodeId=846811946280a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1466167480, createdName=ms3000000089219083, createdTime=Thu Feb 17 23:21:43 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191893, encodeId=0f711191893e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d995020738, createdName=3254357, createdTime=Thu Feb 10 17:18:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 3254357

    学习

    0

Baidu
map
Baidu
map
Baidu
map